Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 2,766 | 3,659 | 5,672 | 2,427 | 2,489 |
| Operating Income | -2,766 | -3,659 | -5,672 | -2,427 | -2,489 |
| Other Income | 104,353 | 53,099 | 15,469 | 61,878 | 15,623 |
| Pre-tax Income | 101,587 | 49,440 | 9,797 | 59,451 | 13,134 |
| Income Tax | 23,431 | 11,130 | -212 | 11,062 | -126 |
| Net Income Continuous | 78,156 | 38,310 | 10,009 | 48,389 | 13,260 |
| Minority Interests | N/A | N/A | N/A | -6 | -28 |
| Net Income | $78,156 | $38,310 | $10,009 | $48,395 | $13,288 |
| EPS Basic Total Ops | 1.90 | 0.94 | 0.24 | 1.16 | 0.32 |
| EPS Basic Continuous Ops | 1.90 | 0.94 | 0.26 | 1.16 | 0.32 |
| EPS Diluted Total Ops | 1.84 | 0.91 | 0.15 | 1.13 | 0.31 |
| EPS Diluted Continuous Ops | 1.84 | 0.91 | 0.25 | 1.13 | 0.31 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.16 | -0.06 | 0.00 | -0.05 |
| EBITDA(a) | $-2,735 | $-3,629 | $-5,642 | $-2,396 | $-2,459 |